This analysis revealed that patients in this tumor cohort whose tumors expressed any PR gene signature (that is, indicative of transcriptionally active PRs) experienced significantly reduced distant metastasis free survival (P = 0.000785; Figure 5C). This evidence concerns the gene PGR and neoplasm.